Skip to main content

Table 2 Body mass index and medications in patients participated in two groups receiving high and low doses of vitamin D in the beginning and the end of the study *

From: The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status

Variables Time of the study P-valuea
Beginning of study End of study
Body mass index (kg/m2)
 High dose group 24.29 ± 3.61 24.69 ± 3.34 0.087
 Low dose group 25.56 ± 4.27 25.69 ± 4.39 0.192
P-valueb 0.284 0.382  
Dose of Azathioprine (mg/day)
 High dose group 87.50 ± 25 87.50 ± 25 1
 Low dose group 83.33 ± 35.35 83.33 ± 35.55 1
P-valueb 0.837 0.837  
Dose of Corticosteroid (mg/day)
 High dose group 2.5 ± 7.3 0.9 ± 2.5 0.16
 Low dose group 0.2 ± 1.0 0 0.32
P-valueb 0.16 0.10  
Dose of Mesalamine (mg/day)
 High dose group 2473.68 ± 1123.90 2450 ± 1099.04 0.331
 Low dose group 2523.81 ± 872.87 2523.81 ± 872.87 0.696
P-valueb 0.875 0.813  
  1. * Values are reported as Mean ± standard deviation
  2. awithin groups; b between groups